Cure Kids

Cure Kids Ventures (CKV) is a seed and early-stage venture capital fund based in Auckland, New Zealand, established in 2008 as part of Cure Kids, a leading child health research charity. CKV invests in the commercialization of innovations that have the potential to improve child health globally. The fund focuses on healthcare-related sectors, including medical devices, biotechnology, diagnostics, medications, and health information systems. Its mission aligns closely with Cure Kids’ vision of a healthier future for children, supporting solutions that can make a significant impact on pediatric care​. CKV typically invests in pre-seed, seed, and Series A rounds, with initial investments ranging from under $500,000 to $3 million. The fund is highly selective, emphasizing strong commercialization potential. CKV has built an impressive portfolio, backing companies like the a2 Milk Company, Pictor, and The Clinician, which are making waves in health tech and biotech industries. Their investments are strategically aimed at driving innovations that address critical health challenges faced by children. The team at CKV brings global experience in biotechnology and healthcare, providing not only financial backing but also valuable insights into early-stage development and commercialization. CKV has played a crucial role in fostering the growth of New Zealand’s healthcare innovation ecosystem, and its impact extends beyond capital, as it works closely with startups to help them achieve market success.